Nephro-Urology Monthly

Published by: Shiraz University of Medical Sciences

Prevalence of White Coat Hypertension in Patients with Chronic Kidney Disease

Rozita Mohd 1 , * , Noor Hidayah Yahya 1 , Rizna Abdul Cader 1 , Halim A Gafor 1 , Yazmin Yaacob 1 and Rozita Hod 2
Authors Information
1 Nephrology Unit, Department of Radiology1, Universiti Kebangsaan Malaysia, Kuala Lumpur, Malaysia
2 Department of Health and Statistics2, Universiti Kebangsaan Malaysia, Kuala Lumpur, Malaysia
Article information
  • Nephro-Urology Monthly: March 2018, 10 (2); e61774
  • Published Online: March 12, 2018
  • Article Type: Research Article
  • Received: December 21, 2017
  • Accepted: February 3, 2018
  • DOI: 10.5812/numonthly.61774

To Cite: Mohd R, Hidayah Yahya N, Abdul Cader R, Gafor H A, Yaacob Y, et al. Prevalence of White Coat Hypertension in Patients with Chronic Kidney Disease, Nephro-Urol Mon. 2018 ;10(2):e61774. doi: 10.5812/numonthly.61774.

Abstract
Copyright © 2018, Nephro-Urology Monthly. This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited
1. Background
2. Methods
3. Results
4. Discussion
Acknowledgements
References
  • 1. Sarafidis PA, Li S, Chen SC, Collins AJ, Brown WW, Klag MJ, et al. Hypertension awareness, treatment, and control in chronic kidney disease. Am J Med. 2008;121(4):332-40. doi: 10.1016/j.amjmed.2007.11.025. [PubMed: 18374693].
  • 2. Salman M, Khan AH, Adnan AS, Sulaiman SA, Hussain K, Shehzadi N, et al. Attributable causes of chronic kidney disease in adults: a five-year retrospective study in a tertiary-care hospital in the northeast of the Malaysian Peninsula. Sao Paulo Med J. 2015;133(6):502-9. doi: 10.1590/1516-3180.2015.005. [PubMed: 26760124].
  • 3. Ravera M, Re M, Deferrari L, Vettoretti S, Deferrari G. Importance of blood pressure control in chronic kidney disease. J Am Soc Nephrol. 2006;17(4 Suppl 2):S98-103. doi: 10.1681/ASN.2005121319. [PubMed: 16565257].
  • 4. Tedla FM, Brar A, Browne R, Brown C. Hypertension in chronic kidney disease: navigating the evidence. Int J Hypertens. 2011;2011:132405. doi: 10.4061/2011/132405. [PubMed: 21747971].
  • 5. Hanratty R, Chonchol M, Miriam Dickinson L, Beaty BL, Estacio RO, Mackenzie TD, et al. Incident chronic kidney disease and the rate of kidney function decline in individuals with hypertension. Nephrol Dial Transplant. 2010;25(3):801-7. doi: 10.1093/ndt/gfp534. [PubMed: 19889870].
  • 6. Agarwal R, Andersen MJ. Prognostic importance of clinic and home blood pressure recordings in patients with chronic kidney disease. Kidney Int. 2006;69(2):406-11. doi: 10.1038/sj.ki.5000081. [PubMed: 16408134].
  • 7. Clinical Practice Guidelines for the management of Blood pressure in chronic kidney disease. 2. Kidney International; 2012.KDIGO. p. 357-62.
  • 8. Mojon A, Ayala DE, Pineiro L, Otero A, Crespo JJ, Moya A, et al. Comparison of ambulatory blood pressure parameters of hypertensive patients with and without chronic kidney disease. Chronobiol Int. 2013;30(1-2):145-58. doi: 10.3109/07420528.2012.703083. [PubMed: 23181690].
  • 9. Ohkubo T, Kikuya M, Metoki H, Asayama K, Obara T, Hashimoto J, et al. Prognosis of "masked" hypertension and "white-coat" hypertension detected by 24-h ambulatory blood pressure monitoring 10-year follow-up from the Ohasama study. J Am Coll Cardiol. 2005;46(3):508-15. doi: 10.1016/j.jacc.2005.03.070. [PubMed: 16053966].
  • 10. Dharmashankar K, Widlansky ME. Vascular endothelial function and hypertension: insights and directions. Curr Hypertens Rep. 2010;12(6):448-55. doi: 10.1007/s11906-010-0150-2. [PubMed: 20857237].
  • 11. O'Brien E, Parati G, Stergiou G. Ambulatory blood pressure measurement: what is the international consensus?. Hypertension. 2013;62(6):988-94. doi: 10.1161/HYPERTENSIONAHA.113.02148. [PubMed: 24060895].
  • 12. Fagard RH, Cornelissen VA. Incidence of cardiovascular events in white-coat, masked and sustained hypertension versus true normotension: a meta-analysis. J Hypertens. 2007;25(11):2193-8. doi: 10.1097/HJH.0b013e3282ef6185. [PubMed: 17921809].
  • 13. Gorostidi M, Vinyoles E, Banegas JR, de la Sierra A. Prevalence of white-coat and masked hypertension in national and international registries. Hypertens Res. 2015;38(1):1-7. doi: 10.1038/hr.2014.149. [PubMed: 25319601].
  • 14. Andersen MJ, Khawandi W, Agarwal R. Home blood pressure monitoring in CKD. Am J Kidney Dis. 2005;45(6):994-1001. [PubMed: 15957127].
  • 15. Minutolo R, Borrelli S, Scigliano R, Bellizzi V, Chiodini P, Cianciaruso B, et al. Prevalence and clinical correlates of white coat hypertension in chronic kidney disease. Nephrol Dial Transplant. 2007;22(8):2217-23. doi: 10.1093/ndt/gfm164. [PubMed: 17420167].
  • 16. Shafi S, Sarac E, Tran H. Ambulatory blood pressure monitoring in patients with chronic kidney disease and resistant hypertension. J Clin Hypertens (Greenwich). 2012;14(9):611-7. doi: 10.1111/j.1751-7176.2012.00675.x. [PubMed: 22947359].
  • 17. Mancia G, Fagard R, Narkiewicz K, Redon J, Zanchetti A, Bohm M, et al. 2013 ESH/ESC guidelines for the management of arterial hypertension: the Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). Eur Heart J. 2013;34(28):2159-219. doi: 10.1093/eurheartj/eht151. [PubMed: 23771844].
  • 18. Agarwal R, Andersen MJ. Blood pressure recordings within and outside the clinic and cardiovascular events in chronic kidney disease. Am J Nephrol. 2006;26(5):503-10. doi: 10.1159/000097366. [PubMed: 17124383].
  • 19. Bangash F, Agarwal R. Masked hypertension and white-coat hypertension in chronic kidney disease: a meta-analysis. Clin J Am Soc Nephrol. 2009;4(3):656-64. doi: 10.2215/CJN.05391008. [PubMed: 19261815].
  • 20. Jensky NE, Criqui MH, Wright MC, Wassel CL, Brody SA, Allison MA. Blood pressure and vascular calcification. Hypertension. 2010;55(4):990-7. doi: 10.1161/HYPERTENSIONAHA.109.147520. [PubMed: 20176996].
  • 21. Di Lullo L, Gorini A, Russo D, Santoboni A, Ronco C. Left Ventricular Hypertrophy in Chronic Kidney Disease Patients: From Pathophysiology to Treatment. Cardiorenal Med. 2015;5(4):254-66. doi: 10.1159/000435838. [PubMed: 26648942].
  • 22. Cuspidi C, Sala C, Tadic M, Rescaldani M, Grassi G, Mancia G. Is white-coat hypertension a risk factor for carotid atherosclerosis? A review and meta-analysis. Blood Press Monit. 2015;20(2):57-63. doi: 10.1097/MBP.0000000000000094. [PubMed: 25405819].
  • 23. Guideline for Management of Hypertension. 2013.Malaysian Clinical Practice. p. 3-6.
  • 24. Monegat M, Sermet C, Rococo E. Polypharmacy: Definitions, Measurement and Stakes Involved. Questions d'economie de la sante. 2014:5-6.
  • 25. Grossman A, Prokupetz A, Koren-Morag N, Grossman E, Shamiss A. Comparison of usefulness of Sokolow and Cornell criteria for left ventricular hypertrophy in subjects aged <20 years versus >30 years. Am J Cardiol. 2012;110(3):440-4. doi: 10.1016/j.amjcard.2012.03.047. [PubMed: 22534054].
  • 26. Agarwal R, Light RP. Determinants and prognostic significance of electrocardiographic left ventricular hypertrophy criteria in chronic kidney disease. Clin J Am Soc Nephrol. 2011;6(3):528-36. doi: 10.2215/CJN.07770910. [PubMed: 21088286].
  • 27. Stein JH, Korcarz CE, Hurst RT, Lonn E, Kendall CB, Mohler ER, et al. Use of carotid ultrasound to identify subclinical vascular disease and evaluate cardiovascular disease risk: a consensus statement from the American Society of Echocardiography Carotid Intima-Media Thickness Task Force. Endorsed by the Society for Vascular Medicine. J Am Soc Echocardiogr. 2008;21(2):93-111. quiz 189-90. doi: 10.1016/j.echo.2007.11.011. [PubMed: 18261694].
  • 28. Muntner P, Judd SE, Krousel-Wood M, McClellan WM, Safford MM. Low medication adherence and hypertension control among adults with CKD: data from the REGARDS (Reasons for Geographic and Racial Differences in Stroke) Study. Am J Kidney Dis. 2010;56(3):447-57. doi: 10.1053/j.ajkd.2010.02.348. [PubMed: 20471734].
  • 29. Kovesdy CP, Trivedi BK, Kalantar-Zadeh K, Anderson JE. Association of low blood pressure with increased mortality in patients with moderate to severe chronic kidney disease. Nephrol Dial Transplant. 2006;21(5):1257-62. doi: 10.1093/ndt/gfk057. [PubMed: 16421161].
  • 30. Lim YN, Ong LM, Goh BL. 21st report of the malaysian dialysis & transplant registry. 2013.
  • 31. Ridao N, Luno J, Garcia de Vinuesa S, Gomez F, Tejedor A, Valderrabano F. Prevalence of hypertension in renal disease. Nephrol Dial Transplant. 2001;16 Suppl 1:70-3. [PubMed: 11369826].
  • 32. Sinha AD, Agarwal R. The complex relationship between CKD and ambulatory blood pressure patterns. Adv Chronic Kidney Dis. 2015;22(2):102-7. doi: 10.1053/j.ackd.2015.01.003. [PubMed: 25704346].
  • 33. Middleton RJ, Parfrey PS, Foley RN. Left ventricular hypertrophy in the renal patient. J Am Soc Nephrol. 2001;12(5):1079-84. [PubMed: 11316868].
  • 34. Cuspidi C, Rescaldani M, Sala C, Grassi G. Left-ventricular hypertrophy and obesity: a systematic review and meta-analysis of echocardiographic studies. J Hypertens. 2014;32(1):16-25. doi: 10.1097/HJH.0b013e328364fb58. [PubMed: 24309485].
  • 35. Wong CY, O'Moore-Sullivan T, Leano R, Byrne N, Beller E, Marwick TH. Alterations of left ventricular myocardial characteristics associated with obesity. Circulation. 2004;110(19):3081-7. doi: 10.1161/01.CIR.0000147184.13872.0F. [PubMed: 15520317].
  • 36. de Simone G, Schillaci G, Chinali M, Angeli F, Reboldi GP, Verdecchia P. Estimate of white-coat effect and arterial stiffness. J Hypertens. 2007;25(4):827-31. doi: 10.1097/HJH.0b013e32801d1f62. [PubMed: 17351375].
  • 37. Szeto CC, Chow KM, Woo KS, Chook P, Ching-Ha Kwan B, Leung CB, et al. Carotid intima media thickness predicts cardiovascular diseases in Chinese predialysis patients with chronic kidney disease. J Am Soc Nephrol. 2007;18(6):1966-72. doi: 10.1681/ASN.2006101184. [PubMed: 17494886].
  • 38. Zhang L, Zhao F, Yang Y, Qi L, Zhang B, Wang F, et al. Association between carotid artery intima-media thickness and early-stage CKD in a Chinese population. Am J Kidney Dis. 2007;49(6):786-92. doi: 10.1053/j.ajkd.2007.03.011. [PubMed: 17533021].
  • 39. Brzosko S, Lebkowska U, Malyszko J, Hryszko T, Krauze-Brzosko K, Mysliwiec M. Intima media thickness of common carotid arteries is associated with traditional risk factors and presence of ischaemic heart disease in hemodialysis patients. Physiol Res. 2005;54(5):497-504. [PubMed: 15641938].
  • 40. Preston E, Ellis MR, Kulinskaya E, Davies AH, Brown EA. Association between carotid artery intima-media thickness and cardiovascular risk factors in CKD. Am J Kidney Dis. 2005;46(5):856-62. doi: 10.1053/j.ajkd.2005.07.048. [PubMed: 16253725].
  • 41. Tang H, Gong WY, Zhang QZ, Zhang J, Ye ZC, Peng H, et al. Prevalence, determinants, and clinical significance of masked hypertension and white-coat hypertension in patients with chronic kidney disease. Nephrology (Carlton). 2016;21(10):841-50. doi: 10.1111/nep.12672. [PubMed: 26566951].
  • 42. Cavallini MC, Roman MJ, Pickering TG, Schwartz JE, Pini R, Devereux RB. Is white coat hypertension associated with arterial disease or left ventricular hypertrophy?. Hypertension. 1995;26(3):413-9. [PubMed: 7649575].
  • 43. Khattar RS, Senior R, Lahiri A. Cardiovascular outcome in white-coat versus sustained mild hypertension: a 10-year follow-up study. Circulation. 1998;98(18):1892-7. [PubMed: 9799210].
Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .

Search Relations:

Author(s):

Article(s):

Create Citiation Alert
via Google Reader

Readers' Comments